Evidence map›Paper›PMID 41848450›Full record

ArticleJACC. Case reports2026

Primary Cardiac Lymphomas: Diagnosis and Management.

Alexandra Pons-Riverola, Maria Clara Llamedo, Lorcan Ruane, Stamatis Kapetanakis, Kshama Wechalekar, Pui Kwan Chak, Andrew D'Silva, Ian Chau, Alexander R Lyon, Muhummad Sohaib Nazir

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandra Pons-RiverolaCardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom; Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; BioHeart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Maria Clara LlamedoCardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom.
Lorcan RuaneCardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom.
Stamatis KapetanakisGuy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom.
Kshama WechalekarDepartment of Nuclear Medicine, Royal Brompton Hospital, London, United Kingdom.
Pui Kwan ChakDepartment of Histopathology, The Royal Marsden Hospital, London, United Kingdom.
Andrew D'SilvaGuy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom; School of Cardiovascular and Metabolic Medicine and Science, King's College London, London, United Kingdom.
Ian ChauThe Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
Alexander R LyonCardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom.
Muhummad Sohaib NazirCardio-Oncology Service and Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, United Kingdom; School of Biomedical Engineering and Imaging Sciences, King's College London, Guy's and St Thomas' Hospital, London, United Kingdom. Electronic address: sohaib.nazir@kcl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cardiac lymphomas (PCLs) are rare and often present a diagnostic challenge because of nonspecific clinical and imaging findings. Delayed diagnosis may lead to rapid clinical deterioration. We report a case series of 6 patients with PCL diagnosed between 2021 and 2025 at 2 tertiary cardio-oncology centers, illustrating the diagnostic pathway, therapeutic strategies, and clinical outcomes. Multimodality imaging was essential for initial evaluation, but histopathologic confirmation was required in all cases. Surgical biopsy proved to be a safe and effective method for tissue diagnosis. Systemic chemotherapy resulted in significant tumor regression or complete resolution in most patients, whereas surgical debulking was reserved for those with hemodynamic compromise. This case series highlights key diagnostic and management considerations that may assist clinicians facing suspected PCL.

Indexed as

cancercardiac magnetic resonancecomputed tomographyechocardiographyimagingpositron emission tomography

Identifiers

PMID41848450
PMCPMC13104365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.